The role of immunoproteins in the survival of liposomes in the circulation

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 14, Issue 2, 1997, Pages 105-131

  Devine, Dana V ^a,b   Marjan, Jihan M J ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Canadian Red Cross Society   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

complement; drug delivery systems; immune mediated clearance; immunoglobulins; lectin; liposomes; pentraxin

Indexed keywords

DRUG; IMMUNOGLOBULIN; LIPOSOME;

ANTIGEN BINDING; COMPLEMENT ACTIVATION; DRUG BINDING; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; REVIEW;

ANTIGEN-ANTIBODY REACTIONS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; DRUG CARRIERS; HUMANS; IMMUNOGLOBULINS; LIPOSOMES; METABOLIC CLEARANCE RATE; OPSONIN PROTEINS;

EID: 0030935267     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (146)

1. Morgan, B. P., Complement: Clinical Aspects and Relevance to Disease, San Diego: Academic Press, 1990.
2. Devine, D. V., The regulation of complement on cell surfaces, Trans. Med. Rev., 5, 123, 1991.
3. Cooper, N. R., Jensen, F. C., Welsh, R. M., and Oldstone, M. B. A., Lysis of RNA tumor viruses by human serum: Direct antibody-independent triggering of the classical complement pathway, J. Exp. Med., 144, 970, 1976.
4. Rent, R., Ertel, N., Eisenstein, R., and Gewurz, H., C activation by interaction of polyanions and polycations, I. Heparin-protamine induced consumption of complement, J. Immunol., 114, 120, 1975.
5. Agnello, V., Carr, R. I., Koffler, D., and Kunkel, H. G., Gel diffusion reactions of C1q with aggregated gamma-globulin, DNA, and various anionic substances, Fed. Proc., 28, 696, 1969.
6. Loos, M., Bitter-Suermann, D., and Dierich, M., Interaction of the first (C1), the second (C2), and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A, J. Immunol., 112, 935, 1974.
7. Ballou, S. P. and Kushner, I., C-reactive protein and the acute phase response, Adv. Intern. Med., 37, 313, 1992.
8. Osmand, A. P., Friedenson, B., Gewurz, H., Painter, R. H., and Shelton, T. E., Characterization of C-reactive protein and the complement component C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins), Proc. Natl. Acad. Sci. USA, 74, 739, 1977.
9. Lei, K. J., Liu, T., Zon, G., Soravia, E., Liu, Y., and Goldman, N. D., Genomic DNA sequence for human C-reactive protein, J. Biol. Chem., 260, 13377, 1985.
10. Whitehead, A. S., Bruns, G., Markman, A. F., Colten, H. R., and Woods, D. E., Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome, Science, 221, 69, 1983.
11. Volanakis, J. E. and Kaplan, M. H., Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide, Proc. Soc. Exp. Biol. Med., 136, 612, 1971.
12. Kaplan, M. H. and Volanakis, J. E., Interactions of C-reactive protein with the complement system, I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal polysaccharide and with the choline phosphatides, lecithin, and sphingomyelin, J. Immunol., 112, 2135, 1974.
13. Volanakis, J. E. and Wirtz, K. W. A., Interaction of C-reactive protein with artificial phosphatidylcholine bilayers, Nature, 281, 155, 1979.
14. Du Clos, T. W., Zlock, L. T., and Rubin, R. L., Analysis of the binding of C-reactive protein to histones and chromatin, J. Immunol., 141, 4266, 1988.
15. Du Clos, T. W., C-reactive protein reacts with the U1 small nuclear ribonucleoprotein, J. Immunol., 143, 2553, 1989.
16. Jewell, W. S., Marnell, L. L., Rokeach, L. A., and Du Clos, T. W., C-reactive protein binding to the Sm-D protein of snRNTs. Identification of a short polypeptide binding region, Mol. Immunol., 30, 701, 1993.
17. Salonen, E. M., Vartio, T., Hedman, K., and Vaheri, A., Binding of fibronectin by the acute phase-reactant C-reactive protein, J. Biol. Chem., 259, 1496, 1984.
18. Swanson, S. J., McPeek, M. M., and Mortensen, R. F., Characteristics of the binding of human C-reactive protein (CRP) to laminin, J. Cell. Biochem., 40, 121, 1989.
19. DiCamelli, R., Potempa, L. A., Siegel, J., Suyehira, L., Petras, K., and Gewurz, H., Binding reactivity of C-reactive protein for polycations J. Immunol., 125, 1933, 1980.
20. Pepys, M. B., Dash, A. C., Markham, R. E., Thomas, H. C., Williams, B. D., and Petrie, A., Comparative clinical study of protein SAP (amyloid P-component) and C-reactive protein in serum, Clin. Exp. Immunol., 32, 119, 1978.
21. Dyck, R. F., Lockwood, C. M., Kershaw, M., McHugh, N., Duance, V. C., Baltz, M. L., and Pepys, M. B., Amyloid P-component is a constituent of normal human glomerular basement membrane, J. Exp. Med., 152, 1162, 1980.
22. Breathnach, S. M., Melrose, S. M., Bhogal, B., deBeer, F. C., Dyck, R. F., Tennent, G., Black, M. M., and Pepys, M. B., Amyloid P-component is located on elastic fibre microfibrils in normal human tissue, Nature, 293, 652, 1981.
23. Pepys, M. B., Baltz, M. L., deBeer, F. C., Dyck, R. F., Holford, S., Breathnach, S. M., Black, M. M., Tribe, C. R., Evans, D. J., and Feinstein, A., Biology of serum amyloid P-component, Ann. NY Acad. Sci., 389, 286, 1982.
24. Pepys, M. B. and Baltz, M. L., Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein, Adv. Immunol., 34, 141, 1983.
25. Pepys, M. B., Dyck, R. F., deBeer, F. C., Skinner, M., and Cohen, A. S., Binding of serum amyloid P-component (SAP) by amyloid fibrils, Clin. Exp. Immunol., 38, 284, 1979.
26. Painter, R. H., De Escallon, I., Massey, A., Pinteric, L., and Stern, S. B., The structure and binding characteristics of serum amyloid protein (9.5 S alpha-1-glycoprotein), Ann. NY Acad. Sci., 389, 199, 1982.
27. Hind, C. R. K., Collins, P. M., Renn, D., Cook, R. B., Caspi, D., Baltz, M. L., and Pepys, M. B., Binding specificity of serum amyloid P-component for pyruvate acetal of galactose J. Exp. Med., 159, 1058, 1984.
28. 2+-mediated association of human serum amyloid P-component with heparan sulfate and dermatan sulfate, J. Biol. Chem., 262, 1456, 1987.
29. Potempa, L. A., Kubak, B. M., and Gewurz, H., Effect of divalent metal ions and pH upon the binding reactivity of human serum amyloid P-component, a C-reactive protein homologue, for zymosan, J. Biol. Chem., 260, 12142, 1985.
30. Kubak, B. M., Potempa, L. A., Anderson, B., Mahklouf, S., Venegas, M., Gewurz, H., and Gewurz, A. T., Evidence that serum amyloid P-component binds to mannose-terminated sequences of polysaccharides and glycoproteins, Mol. Immunol., 25, 851, 1988.
31. Loveless, R. W., Sullivan, G. F., Raynes, J. G., Yuen, C.-T., and Feizi, T., Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine, and glucuronic acid, Embo J., 11, 813, 1992.
32. deBeer, F. C., Baltz, M. L., Holford, S., Feinstein, A., and Pepys, M. B., Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P-component, J. Exp. Med., 154, 1134, 1981.
33. Bristow, C. L. and Boackle, R. J., Evidence for the binding of human serum amyloid P-component to C1q and Fab, Mol. Immunol., 23, 1045, 1986.
34. Schwalbe, R. A., Dahlback, B., and Nelsestuen, G. L., Independent association of serum amyloid P-component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes, J. Biol. Chem., 265, 21749, 1990.
35. Schwalbe, R. A., Dahlback, B., and Nelsestuen, G. L., Heparin influence on the complex of serum amyloid P-component and complement C4b-binding protein, J. Biol. Chem., 266, 12896, 1991.
36. Hutchcraft, C. L., Gewurz, H., Hansen, B., Dyck, R. F., and Pepys, M. B., Agglutination of complement-coated erythrocytes by serum amyloid P-component, J. Immunol., 126, 1217, 1981.
37. Pepys, M. B. and Butler, P. J. G., Serum amyloid P-component is the major calcium-dependent specific DNA binding protein of the serum, Biochem. Biophys. Res. Commun., 148, 308, 1987.
38. Butler, P. J. G., Tennent, G. A., and Pepys, M. B., Pentraxin-chromatin interactions: Serum amyloid P-component specifically displaces H1-type histones and solubilizes native long chromatin, J. Exp. Med., 172, 13, 1990.
39. Baltz, M. L., deBeer, F. C., Feinstein, A., and Pepys, M. B., Calcium-dependent aggregation of human serum amyloid P-component, Biochim. Biophys. Acta, 701, 229, 1982.
40. Ying, S.-C., Gewurz, A. T., Jiang, H., and Gewurz, H., Human serum amyloid P-component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q1, J. Immunol., 150, 169, 1993.
41. Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., Gitt, H. A., Hirabayashi, J., Hughes, C., and Kasai, K., Galactins: A family of animal β-galactoside-binding lectins, Cell, 76, 597, 1994.
42. Drickamer, K., Biology of animal lectins, Ann. Rev. Cell. Biol., 9, 237, 1993.
43. Drickamer, K., Dordal, M. S., and Reynolds, L., Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails: Complete primary structures and homology with pulmonary surfactant apoprotein, J. Biol. Chem., 26, 6878, 1986.
44. Ezekowitz, R. A. B., Day, L. E., and Herman, G. A., Human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins, J. Exp. Med., 167, 1034, 1988a.
45. Thiel, S., Holmskov, U., Hviid, L., Laursen, S. B., and Jensenius, J. C., The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response, Clin. Exp. Immunol., 90, 31, 1992.
46. Lu, J. H., Thiel, S., Wiedemann, H., Timpl, R., and Reid, K. B., Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1rC1s2 complex of the classical pathway of complement without involvement of C1a, J. Immunol., 144, 2287, 1990.
47. Malhorta, R., Thiel, S., Reid, K. B. M., and Sim, R. B., Human leukocytes C1q receptor binds other soluble proteins with collagen domains, J. Exp. Med., 172, 955, 1990.
48. Hartshorn, K. L, Sastry, K., White, M. R., Anders, E. M., Super, M., Ezekowitz, R. A., and Tauber, A. I., Human mannose-binding protein functions as an opsonin for influenza A viruses, J. Clin. Invest., 91, 1414, 1993.
49. Ikeda, K., Sannoh, T., Kawasaki, N., Kawasaki, T., and Yamashina, I., Serum lectin with known structure activates complement through the classical pathway, J. Biol. Chem., 262, 7451, 1987.
50. Ohta, M., Okada, M., Yamashina, I., and Kawasaki, T., The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein, J. Biol. Chem., 265, 1980, 1990.
51. Ihara, I., Harada, T., Ihara, S., and Kawakami, M., A new complement-dependent bactericidal factor found in nonimmune mouse sera: Specific binding to polysaccharide of Ra chemotype, Salmonella, J. Immunol., 128, 1256, 1982.
52. Ji, Y., Matsushita, M., Okada, H., Fujita, T., and Kawakami, M., The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor, J. Immunol., 141, 4271, 1988.
53. Super, M., Levinsky, R. J., and Turner, M. W., The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations, Clin. Exp. Immunol., 79, 144, 1990.
54. Kawasaki, N., Kawasaki, T., and Yamashina, I., A serum lectin (mannan binding protein) has complement-dependent bactericidal activity, J. Biochem. Tokyo, 106, 483, 1989.
55. Ihara, S., Takahashi, A., Hatsuse, H., Sumitomo, K., Doi, K., and Kawakami, M., Major component of Ra-reactive factor, a complement-activating bactericidal protein, in mouse serum, J. Immunol., 146, 1874, 1991.
56. Matsushita, M., Takahashi, A., Hatsuse, H., Kawakami, M., and Fujita, T., Human mannose-binding is identical to a component of Ra-reactive factor, Biochem. Biophys. Res. Commun., 183, 645, 1992.
57. Matsushita, M. and Fujita, T., Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease, J. Exp. Med., 176, 1497, 1992.
58. Takada, F., Takayama, Y., Hatsuse, H., and Kawakami, M., A new member of the C1s family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum, Biochem. Biophys. Res. Commun., 196, 1003, 1993.
59. Takayama, Y., Takada, F., Takahashi, A., and Kawakami, M., A 100 kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s, J. Immunol., 152, 2308, 1994.
60. Schweinle, J. E., Ezekowitz, R. A. B., Tenner, A. J., Kuhlman, M., and Joiner, K. A., Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of salmonella, J. Clin. Invest., 84, 1821, 1989.
61. Reid, K. B. M., Activation and control of the complement system, Essays Biochem., 22, 27, 1986.
62. Patel, H. M., Serum opsonins and liposomes: Their interaction and opsonophagocytosis, Grit. Rev. Ther. Drug Carrier Syst., 9, 39, 1992.
63. Galanos, C., Rietschel, E. T., Luderitz, O., and Westphal, O., Interaction of lipopolysaccharides and lipid A with complement, Eur. J. Biochem., 19, 143, 1971.
64. Galanos, C. and Luderitz, O., The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity, Eur. J. Biochem., 65, 403, 1976.
65. Mergenhagen, S. E., Gewurz, H., Bladen, H. A., Howotny, A., Kaser, N., and Luderitz, O., Interactions of the complement system with endotoxins from a Salmonella minnesota mutant deficient in O-polysaccharide and heptose, J. Immunol., 100, 227, 1968.
66. Banerji, B. and Alving, C. R., Lipid A from endotoxin: Antigenic activities of purified fractions in liposomes, J. Immunol., 123, 2558, 1979.
67. Cooper, N. R. and Morrison, D. C., Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharide, J. Immunol., 120, 1862, 1978.
68. Tenner, A. J., Ziccardi, R. J., and Cooper, N. R., Antibody-independent C1 activation by E. coli, J. Immunol., 113, 886, 1984.
69. Morrison, D. C. and Kline, L. G., Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS), J. Immunol., 118, 362, 1977.
70. Pommier, C. G., O'Shea, J., Chused, T., Yancey, K., Frank, M. M., Takahashi, T., and Brown, E. J., Studies on the fibronectin receptors of human peripheral blood leukocytes: Morphologic and functional characterization, J. Exp. Med., 159, 137, 1984.
71. Nishioka, K., Amojcato, A. A, and Babcock, G. F., Minireview, tuftsin: A hormone-like tetrapeptide with antimicrobial and antitumor activities, Life Sci., 28, 1081, 1981.
72. Knisely, M. H., Bloch, E. H., and Marner, L., Selective phagocytosis, K. Dan. Vidensk. Biol., 4, 1, 1948.
73. Stollerman, G. H., Rytel, M., and Ortiz, J., Accessory plasma factors involved in the bactericidal test for type-specific antibody to Group A streptococci, J. Exp. Med., 117, 1, 1963.
74. Ghebrehiwet, B., Silverberg, M., and Kaplan, A. P., Activation of the classical pathway of complement by Hageman factor fragment, J. Exp. Med., 153, 665, 1981.
75. Wright, S. D. and Meyer, B. C., Fibronectin receptor of human macrophages recognizes the sequence arg-gly-asp-ser, J. Exp. Med., 162, 767, 1985.
76. Chonn, A., Semple, S. C., and Cullis, P. R., Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes, J. Biol. Chem., 267, 18759, 1992.
77. Alving, C. R. and Richards, R. L., Immunologic aspects of liposomes, in Liposomes, Ostro, M.J., Ed., New York, Marcel-Dekker, 1983, 209.
78. Juliano, R. L. and Stamp, D., The effect of particle size and charge on the clearance rates of liposomes and liposome-encapsulated drugs, Biochem. Biophys. Res. Commun., 63, 651, 1975.
79. Juliano, R. L. and Lin, G., The interaction of plasma proteins with liposomes: Protein binding and the effects of the clotting and complement system, in Liposomes and Immunobiology, Tom, B. H. and Six, H. R., Eds., Elsevier N-Holland, 1980, 49.
80. Juliano, R. L., Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres, and emulsions, Adv. Drug Del. Rev., 2, 31, 1988.
81. Bonte, F. and Juliano, R. L., Interactions of liposomes with serum proteins, Chem. Phys. Lipids, 40, 359, 1986.
82. Shin, M. L., Paznekas, W. A., and Mayer, M. M., On the mechanism of membrane damage by complement: The effect of length and unsaturation of the acyl chains in liposomal bilayers and the effect of cholesterol concentration in sheep erythrocyte and liposomal membranes, J. Immunol., 120, 1996, 1978.
83. Drickamer, K., Two distinct classes of carbohydrate-recognition domains in animal lectins, J. Biol. Chem., 263, 9557, 1988.
84. Chonn, A., Cullis, P. R., and Devine, D. V., The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes, J. Immunol., 146, 4234, 1991.
85. Alving, C. R., Richards, R. L., and Guirguis, A. A., Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes, J. Immunol., 118, 342, 1977.
86. Thielens, N. M. and Colomb, M. G., A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway), Eur. J. Immunol., 16, 617, 1986.
87. Kovacsovics, T., Tschopp, J., Kress, A., and Isliker, H., Antibody-independent activation of C1, the first component of complement, by cardiolipin. J. Immunol., 140, 1581, 1991.
88. Marjan, J., Xie, Z. and Devine, D. V., Liposome-induced activation of the classical complement pathway does not require immunoglobulin, Biochim. Biophys. Acta, 1192, 35, 1994.
89. Cunningham, C. M., Kingzette, M., Richards, M. L., Alving, C. R., Lint, T. F., and Gewurz, H., Activation of human complement by liposomes: A model for membrane activation of the alternative pathway, J. Immunol., 122, 1237, 1979.
90. Devine, D. V., Wong, K., Serrano, K., Chonn, A., and Cullis, P. R., Liposome-complement interactions in rat serum: Implications for liposome survival studies, Biochim. Biophys. Acta, 1191, 43, 1994.
91. Okada, N., Yasuda, T., Tsumita, T., and Okada, H., Differing reactivities of human and guinea-pig complement on haptenized liposomes via the alternative pathway, Mol. Immunol., 20, 857, 1983.
92. Okada, N., Yasuda, T., Tsumita, T., and Okada, H., Activation of the alternative complement pathway of guinea pig by liposomes incorporated with trinitrophenylated phosphatidylethanolamine, Immunology, 45, 115, 1982.
93. Liu, Z. Y., Solow, R., and Hu, V. W., Fluorescence analysis of size distribution and mode of dye release from carboxyfluorescein-loaded vesicles: Application to the study of complement-membrane interactions, Biochim. Biophys. Acta, 945, 253, 1988.
94. Richards, R. L., Habbersett, R. C., Scher, I., Janoff, A. S., Schieren, H. P., Mayer, L. D., Cullis, P. R., and Alving, C. R., Influence of vesicle size on complement-dependent immune damage to liposomes, Biochim. Biophys. Acta, 855, 223, 1986.
95. Hsu, M. J. and Juliano, R. L., Interactions of liposomes with the reticuloendothelial system, II. Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages, Biochim. Biophys. Acta, 720, 411, 1982.
96. Roerdink, F., Wassef, N. M., Richardson, E. C., and Alving, C. R., Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement, Biochim. Biophys. Acta, 734, 33, 1983.
97. Lee, K.-D., Hong, K., and Papahadjopoulos, D., Recognition of liposomes by cells: In vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density, Biochim. Biophys. Acta, 1103, 185, 1992.
98. Allen, T. A., Austin, G. A., Chonn, A., Lin, L., and Lee, K. C., Uptake of liposomes by cultured mouse bone marrow macrophages: Influence of liposome composition and size, Biochim. Biophys. Acta, 1061, 56, 1991.
99. Wassef, N. M., Matyas, G. R., and Alving, C. R., Complement-dependent phagocytosis of liposomes by macrophages: Suppressive effects of "stealth" lipids, Biochem. Biophys. Res. Comm., 176, 866, 1991.
100. Moghimi, S. M. and Patel, H. M., Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes, Biochim. Biophys. Acta, 984, 384, 1989.
101. Moghimi, S. M. and Patel, H. M., Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells, Biochim. Biophys. Acta, 1135, 269, 1992.
102. Harashima, H., Sakata, K., Funato, K., and Kiwada, H., Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes, Pharm. Res., 11, 402, 1994.
103. Matsuo, H., Funato, K., Harashima, H., and Kiwada, H., The complement-but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ, J. Drug Target., 2, 141, 1994.
104. Scieszka, J. F., Maggiora, L. L., Wright, S. D., and Cho, M. J., Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils, Pharm. Res., 8, 65, 1991.
105. Wassef, N. A., Johnson, S. H., Graeber, G. M., Swartz, G. M., Schultz, C. L., Hailey, J. R., Johnson, A. J., Taylor, D. G., Ridgway, R. L., and Alving, C. R., Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs, J. Immunol., 143, 2990, 1989.
106. Aramaki, Y., Murai, M., and Tsuchiya, S., Activation of Fc receptor-mediated phagocytosis by mouse peritoneal macrophages following the intraperitoneal administration of liposomes, Pharm. Res., 11, 518, 1994.
107. Leserman, L. D., Weinstein, J. N., Blumenthal, R., and Terry, W. D., Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells, Proc. Natl. Acad. Sci. USA, 77, 4089, 1980.
108. Roubey, R. A. S., Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies, Blood, 84, 2854, 1994.
109. Alving, C. R., Natural antibodies against phospholipids and liposomes in humans, Biochem. Soc. Trans., 12, 342, 1984.
110. McNeil, H. P., Simpson, R. J., and Chesterman, C. N., Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H), Proc. Natl. Acad. Sci. USA, 87, 4120, 1990.
111. Pengo, V., Biasiolo, A., and Fior, M. G., Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface, Thromb. Hæmost, 73, 29, 1995.
112. Bick, R. L., The antiphospholipid-thrombosis syndromes, Am. J. Clin. Pathol., 100, 477, 1993.
113. Kouts, S., Wang, M.-X., Adelstein, S., and Krilis, S. A., Immunization of a rabbit with β2-glycoprotein I induced charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies, J. Immunol., 155, 958, 1995.
114. Kaise, S., Yasuda, T., Kasukawa, R., Nishimaki, T., Watarai, S., and Tsumita, T., Anti-glycolipid antibodies in normal and pathologic human sera and synovial fluids, Vax Sang., 49, 292, 1985.
115. Claus, D. R., Siegel, J., Petras, K., Osmand, A. P., and Gewurz, H., Interactions of C-reactive protein with the first component of human complement, J. Immunol., 119, 187, 1977.
116. Jiang, H., Robey, F. A., and Gewurz, H., Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain, J. Exp. Med., 175, 1373, 1992.
117. Richards, R. L., Gewurz, H., Osmand, A. P., and Alving, C. R., Interactions of C-reactive protein and complement with liposomes, Proc. Natl. Acad. Sci. USA, 74, 5672, 1977.
118. Volanakis, J. E. and Narkates, A. J., Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement, J. Immunol., 126, 1820, 1981.
119. Mold, C., Kingzette, M., and Gewurz, H., C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b1, J. Immunol., 133, 882, 1984.
120. Mold, C. and Gewurz, H., Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniæ, J. Immunol., 127, 2089, 1981.
121. Richards, R. L., Gewurz, H., Siegel, J., and Alving, C. R., Interactions of C-reactive protein and complement with liposomes, II. Influence of membrane composition, J. Immunol., 122, 1185, 1979.
122. Deodhar, S. D., James, K., Chiang, T., Edinger, M., and Barna, B., Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein, Cancer Res., 42, 5084, 1982.
123. Barna, B. P., Deodhar, S. D., Gautam, S., Yen-Lieberman, B., and Roberts, D., Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein, Cancer Res., 44, 305, 1984.
124. Dahlback, B., Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S, Biochem. J., 209, 847, 1983.
125. Nagasawa, S. and Stroud, R. M., Purification and characterization of a macromolecular weight cofactor for C3b-inactivation, C4bC3bINA-cofactor, of human plasma, Mol. Immunol., 17, 1365, 1980.
126. Scharfstein, J., Ferreira, A., Gigli, I., and Nussenzweig, V., Human C4-binding protein, I. Isolation and characterization, J. Exp. Med., 148, 207, 1978.
127. Hillarp, A. and Dahlback, B., Cloning of cDNA coding for the β chain of human complement component C4b-binding protein: Sequence homology with the a chain, Proc. Natl. Acad. Sci. USA, 87, 1183, 1990.
128. Hillarp, A. and Dahlback, B., Novel subunit in C4b-binding protein required for protein S binding, J. Biol. Chem., 263, 12759, 1988.
129. Nelsestuen, G. L., Kisiel, W., and Di Scipio, R. G., Interaction of vitamin K-dependent proteins with membranes, Biochemistry, 17, 2134, 1978.
130. Op Den Kamp, J. A., Lipid asymmetry in membranes, Annu. Rev. Biochem., 48, 47, 1979.
131. Zwaal, R. F. A., Membrane and lipid involvement in blood coagulation, Biochim. Biophys. Acta., 515, 163, 1978.
132. Schwalbe, R., Dahlback, B., Hillarp, A., and Nelsestuen, G. L., Assembly of protein S and C4b-binding protein on membranes, J. Biol. Chem., 265, 16074, 1990.
133. Schwalbe, R. A., Dahlback, B., Coe, J. E., and Nelsestuen, G. L., Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine, Biochemistry, 31, 4907, 1992.
134. Garcon, N., Gregoriadis, G., Taylor, M., and Summerfield, J., Mannose mediated immunoadjuvant action of liposomes, Immunology, 64, 743, 1988.
135. Ezekowitz, R. A. B., Sim, R., Hill, M., and Gordon, S., Local opsonization by secreted macrophage components: Role of receptors for complement in uptake of zymosan, J. Exp. Med., 154, 244, 1984.
136. Ezekowitz, R. A. B. and Stahl, P. S., The function of vertebrate mannose lectin like proteins, J. Cell. Sci., Suppl. 9, 121, 1988b.
137. Strunk, R. C., Whitehead, A. S., and Cole, F. S., Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide, J. Clin. Invest., 76, 985, 1985.
138. Strunk, R. C., Eidlen, D. M., and Mason, R. J., Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways, J. Clin. Invest., 81, 1419, 1988.
139. Katz, Y., Cole, F. S., and Strunk, R. C., Synergism between Interferon-γ and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblasts, J. Exp. Med., 167, 1, 1988.
140. Verma, J. N., Rao, M., Amselem, S., Krzych, U., Alving, C. R., Green, S. J., and Wassef, N. M., Adjuvant effects of liposomes containing lipid A: Enhancement of liposomal antigen presentation and recruitment of macrophages, Infect. Immun., 60, 2438, 1992.
141. van Rooijen, N. and van Nieuwmegen, R., Endotoxin enhanced adjuvant effect of liposomes, particularly when antigen and endotoxin are incorporated within the same liposome, Immunol. Comm., 9, 747, 1980.
142. Kinsky, S. C., Effects of lipid A on the immunologic properties of liposomal model membranes, Rev. Infect. Dis., 6, 558, 1984.
143. Loos, M., Biosynthesis of the collagen-like C1q molecule and its receptor functions for Fc and polyanionic molecules on macrophages, Curr. Top. Microbiol. Immunol., 102, 1, 1983.
144. Loos, M., Muller, W., Boltz-Nitulescu, G., and Forster, O., Evidence that C1q, a sub-component of the first component of complement, is an Fc receptor of peritoneal and alveolar macrophages, Immunobiology, 157, 54, 1980.
145. Martin, H., Heinz, H.-P., Reske, K., and Loos, M., Macrophage C1q: Characterization of a membrane form of C1q and of multimers of C1q subunits, J. Immunol., 138, 3863, 1987.
146. Chonn, A., Cullis, P. R., and Devine, D. V., The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes, J. Immunol., 146, 4234, 1991.